biosimilar

Biosimilars don’t need big market share to bring savings – IMS

https://pharmaphorum.com/news/biosimilars-dont-need-big-market-share-to-bring-savings-ims/

US regulatory advisers to review Amgen’s Humira biosimilar

https://pharmaphorum.com/news/us-regulatory-advisers-review-amgens-biosimilar/

Janssen’s RA candidate among hot topics at EULAR

https://pharmaphorum.com/news/janssens-ra-candidate-among-hot-topics-eular/

Eye on ASCO Day 1 – There’s life in the old drugs yet

https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-1-theres-life-in-the-old-drugs-yet/

Sandoz bags first-ever biosimilar approval in US

https://pharmaphorum.com/news/sandoz-bags-first-ever-biosimilar-approval-in-us/

«< 2 3 4 5 6

Close in 10 seconds

Pharmaphorum.com

Search